Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNQ7W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,607
Award facts
- Contract value 100% obligated
- $19,607.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,607.28 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of BIMZELX 320 MG/2 ML Auto-Injector units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 30, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The product will be performed and shipped from the company's location in Conshohocken, Pennsylvania. BIMZELX is a biologic immunosuppressant medication used to treat inflammatory conditions, and this delivery order fulfills military healthcare supply requirements through the agency's medical procurement channels.
This delivery order is issued under AmerisourceBergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare systems and the Defense Health Agency. The company's extensive contract history with the DLA demonstrates its proven capability to meet federal procurement requirements through competitive award processes, positioning it as a primary supplier within the agency's pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26FNQ7W?
SPE2DR26FNQ7W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FNQ7W worth?
The government has obligated $19,607 on SPE2DR26FNQ7W.
Is contract SPE2DR26FNQ7W an order under another contract?
Yes. SPE2DR26FNQ7W is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNQ7W competed?
The extent of competition for SPE2DR26FNQ7W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award